Lisinopril And Hydrochlorothiazide
Product Images NDC 67296-0921

1 FDA label image from Redpharm Drug, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 67296-0921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lisinopril/hctz 20/12.5 (Doc20170426134238 001)

Lisinopril/hctz 20/12.5 (Doc20170426134238 001)
This image shows two rectangular drug labels for Lisinopril and Hydrochlorothiazide tablets, each with a strength of 20 mg/12.5 mg. The top label indicates a package of 90 tablets with an expiration date of 11/15, manufactured by Lupin Limited in India and distributed by RedPharm Drug, Inc. The bottom label indicates a package of 30 tablets with an expiration date of 05/18, with the same manufacturer and distributor. Both labels include a barcode, NDC numbers, lot numbers, and storage temperature instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.